Okteva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Okteva, is a somatostatin analog presented as a formulation for injection use. It is employed in the management of hormone‑secreting tumors and related endocrine disorders in adult patients. GNH USA supplies Okteva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Okteva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Okteva is a somatostatin analog that modulates hormone secretion in several endocrine‑related conditions.

- Acromegaly: reduces excessive growth hormone production and helps control disease activity. - Neuroendocrine tumors: controls symptoms associated with hormone hypersecretion. - Carcinoid syndrome: alleviates flushing and diarrhea caused by serotonin excess. - Vaso‑vascular vascular vascular  - Vascular  - 

Common  

   t